IL250852B - Periodontal composition - Google Patents

Periodontal composition

Info

Publication number
IL250852B
IL250852B IL250852A IL25085217A IL250852B IL 250852 B IL250852 B IL 250852B IL 250852 A IL250852 A IL 250852A IL 25085217 A IL25085217 A IL 25085217A IL 250852 B IL250852 B IL 250852B
Authority
IL
Israel
Prior art keywords
periodontal
oral cavity
periodontal composition
composition
disease
Prior art date
Application number
IL250852A
Other languages
Hebrew (he)
Other versions
IL250852A0 (en
Inventor
Mevorat Kaplan Keren
Segal Dadi
Rosenbaum Danny
Liapis Igal
Makarovsky Igor
Stern Meir
Original Assignee
Prudentix Ltd
Mevorat Kaplan Keren
Segal Dadi
Rosenbaum Danny
Liapis Igal
Makarovsky Igor
Stern Meir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=61273968&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL250852(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Prudentix Ltd, Mevorat Kaplan Keren, Segal Dadi, Rosenbaum Danny, Liapis Igal, Makarovsky Igor, Stern Meir filed Critical Prudentix Ltd
Priority to IL250852A priority Critical patent/IL250852B/en
Publication of IL250852A0 publication Critical patent/IL250852A0/en
Priority to PCT/IL2018/050217 priority patent/WO2018158763A1/en
Publication of IL250852B publication Critical patent/IL250852B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to an oral delivery composition, more particularly a solid dosage form, for delivering a therapeutic agent, e.g., an antibacterial agent, to a soft tissue in the oral cavity such as a periodontal pocket so as to treat an oral cavity related disease such as periodontal disease; and to a method of use.
IL250852A 2017-02-28 2017-02-28 Periodontal composition IL250852B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL250852A IL250852B (en) 2017-02-28 2017-02-28 Periodontal composition
PCT/IL2018/050217 WO2018158763A1 (en) 2017-02-28 2018-02-27 Periodontal composition and method of use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL250852A IL250852B (en) 2017-02-28 2017-02-28 Periodontal composition

Publications (2)

Publication Number Publication Date
IL250852A0 IL250852A0 (en) 2017-05-01
IL250852B true IL250852B (en) 2018-02-28

Family

ID=61273968

Family Applications (1)

Application Number Title Priority Date Filing Date
IL250852A IL250852B (en) 2017-02-28 2017-02-28 Periodontal composition

Country Status (2)

Country Link
IL (1) IL250852B (en)
WO (1) WO2018158763A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019069298A2 (en) 2018-01-18 2019-04-11 Christian Arnold Chewing gum composition comprising polyhexanide
EP3771337A1 (en) * 2019-07-29 2021-02-03 The Procter & Gamble Company Antimicrobial composition
EP3771338A1 (en) * 2019-07-29 2021-02-03 The Procter & Gamble Company Acidic antimicrobial composition
IL291349B2 (en) * 2022-03-14 2024-03-01 Prudentix Ltd Preparations for removing microbial biofilm or inhibiting its formation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1317358B1 (en) * 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl CROSS-LINKATED DERIVATIVES OF HYALURONIC ACID.
CZ28634U1 (en) * 2015-05-05 2015-09-14 Contipro Pharma A.S. Hyaluronan-based dental preparation and octenidine dihydrochloride
CN105168238A (en) * 2015-08-13 2015-12-23 南京天纵易康生物科技股份有限公司 Hyaluronic temperature-sensitive gel and preparation method and application thereof

Also Published As

Publication number Publication date
IL250852A0 (en) 2017-05-01
WO2018158763A1 (en) 2018-09-07

Similar Documents

Publication Publication Date Title
PH12020500066A1 (en) Carboxamides as modulators of sodium channels
MX2021002321A (en) Novel methods.
EP4272818A3 (en) Thrombolytic agent for the treatment of thromboembolism
MX2022003072A (en) Use of pridopidine for treating functional decline.
MX2016010213A (en) Novel pharmaceutical formulations.
PH12017501421B1 (en) Pharmaceutical compositions comprising n-(3,5-dimethoxyphenyl)-n`-(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine
TW201613578A (en) Pharmaceutical combinations
PH12016502352A1 (en) Pharmaceutical composition
MX2019008999A (en) Injectable composition for preventing hair loss or stimulating hair growth.
MA39765A (en) Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use
MX2020011817A (en) Methods for treating lymphoma.
ZA202000028B (en) Use of vibegron to treat overactive bladder
ZA201805358B (en) 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
MX379201B (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
IL250852B (en) Periodontal composition
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX2020003697A (en) Pharmaceutical formulations comprising opioid receptor agonist as active ingredients, methods of manufacture and therapeutic uses thereof.
ZA201906153B (en) Pharmaceutical compositions for combination therapy
GR1008228B (en) Pharmaceutical composition comprising a dual reuptake inhibitor and method for the preparation thereof
MX2018004774A (en) Substituted morpholine derivatives having activity against pain.
JOP20200005B1 (en) Pharmaceutical compositions
MX2016013889A (en) Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders.
IN2013MU03428A (en)
MX2020001217A (en) Methods of treating symptoms of gastroparesis using velusetrag.